# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-25-033368
Filing Date
2025-04-18
Accepted
2025-04-18 16:07:02
Documents
3
Period of Report
2025-04-18

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRELIMINARY PROXY STATEMENT | ea0238458-pre14a_citius.htm | PRE 14A | 150053
2 | GRAPHIC | image_001.jpg | GRAPHIC | 480625
3 | GRAPHIC | image_002.jpg | GRAPHIC | 359215
| Complete submission text file | 0001213900-25-033368.txt |  | 1308023

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: PRE 14A | Act: 34 | File No.: 001-38174 | Film No.: 25850492
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)